A Phase II, randomized, assessor-blind, placebo-controlled, multicenter, comparative, prospective study to assess the efficacy and safety of Viracure cream in immunocompetent patients with Genital Herpes due to Herpes Simplex Virus -2 infection.

Trial Profile

A Phase II, randomized, assessor-blind, placebo-controlled, multicenter, comparative, prospective study to assess the efficacy and safety of Viracure cream in immunocompetent patients with Genital Herpes due to Herpes Simplex Virus -2 infection.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs PP 9706642 (Primary)
  • Indications Herpes genitalis; Herpes simplex virus type 2 infections
  • Focus Therapeutic Use
  • Sponsors Piramal Phytocare
  • Most Recent Events

    • 03 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top